Results 131 to 140 of about 3,680 (196)

FGF14 repeat length and mosaic interruptions: modifiers of spinocerebellar ataxia 27B? [PDF]

Brain
Laß J, Thomsen M, Borsche M, Lüth T, Prietzsche JC, Schaake S, Milovanović A, Macpherson H, Gustavsson EK, Saffie Awad P, Dragašević-Mišković N, Laabs BH, König IR, Westenberger A, Pearson CE, Brüggemann N, Klein C, Trinh J.   +17 more
europepmc   +1 more source

The roles of TAF1 in neuroscience and beyond. [PDF]

R Soc Open Sci
Crombie EM, Cleverley K, Timmers HTM, Fisher EMC.   +3 more
europepmc   +1 more source

Retrotransposon: an insight into neurological disorders from perspectives of neurodevelopment and aging. [PDF]

Transl Neurodegener
Zhang W, Huang C, Yao H, Yang S, Jiapaer Z, Song J, Wang X.   +6 more
europepmc   +1 more source

Mini-heterochromatin domains constrain the cis-regulatory impact of SVA transposons in human brain development and disease. [PDF]

Nat Struct Mol Biol
Horváth V, Garza R, Jönsson ME, Johansson PA, Adami A, Christoforidou G, Karlsson O, Castilla Vallmanya L, Koutounidou S, Gerdes P, Pandiloski N, Douse CH, Jakobsson J.   +12 more
europepmc   +1 more source

Genomic characterization of Huntington's disease genetic modifiers informs drug target tractability. [PDF]

Brain Commun
Namuli KL, Slike AN, Hollebeke MA, Wright GEB.   +3 more
europepmc   +1 more source

Feasibility of Little Cherry/X-Disease Detection in <i>Prunus avium</i> Using Field Asymmetric Ion Mobility Spectrometry. [PDF]

Sensors (Basel)
Kothawade GS, Khot LR, Chandel AK, Molnar C, Harper SJ, Wright AA.   +5 more
europepmc   +1 more source

Principal variables analysis for non-Gaussian data. [PDF]

J Comput Graph Stat
Clark-Boucher D, Miller JW.
europepmc   +1 more source

Neuroenergetic Changes in Patients with X-Linked Dystonia-Parkinsonism and Female Carriers. [PDF]

Mov Disord Clin Pract
Prasuhn J, Henkel J, Algodon SM, Uter J, Rosales RL, Klein C, Steinhardt J, Diesta CC, Brüggemann N.   +8 more
europepmc   +1 more source

Formulation and Evaluation of Solid Self-Nanoemulsifying Drug Delivery System of Cannabidiol for Enhanced Solubility and Bioavailability. [PDF]

Pharmaceutics
Wu F, Ma Q, Tian G, Chen K, Yang R, Shen J.   +5 more
europepmc   +1 more source

SAICAR Drives T Regulatory Cell Differentiation and FOXP3 Maintenance to Promote Immunotherapy Resistance. [PDF]

Cancer Res
Li M, Chen Y, Liu A, Wu Q, Huang C, Song D, Hu F, Lan J, Huang C, Hu J, Wang G.   +10 more
europepmc   +1 more source